At Amador, we’re committed to leveraging our global network and expert teams to bring innovative drugs to the world stage. Let’s keep up this amazing energy as we continue to break new ground in healthcare!Share this article:This past week at JPM 2024 was nothing short of spectacular, filled with familiar faces, insightful conversation, and an incredible buzz around innovative drug development. We are thrilled with the success of our networking event, which attracted investors worldwide and ma

Earlier this year, the Amador team had the incredible opportunity to engage in a dynamic discussion with the NYSE Cassandra Seier, Head of International Capital Markets and Johanna Grossman, PhD, Head of Healthcare Life Sciences Capital Markets teams at the historic NYSE building.Share this article:Earlier this year, the Amador team had the incredible opportunity to engage in a dynamic discussion with the NYSE Cassandra Seier, Head of International Capital Markets and Johanna Grossman, PhD, Hea

Someone impersonating Amador is trying to commit recruitment scams on the internet. We don't want anyone to fall for this scam. Therefore, Amador wants to emphasize that we will only reach out to job candidates through official ways.Share this article:As a science-driven translational science and clinical development CRO, Amador is fully integrated to accelerate global development of innovative therapies into the global markets.For all talented people out there eager to join Amador: be aware

Exciting news! Last month, we marked our 5th anniversary, and the New York Stock Exchange joined in the celebration by showcasing us on the trading floor. We are truly grateful to the NYSE for this recognition.Share this article:Exciting news! 🎉 Last month, we marked our 5th anniversary, and the New York Stock Exchange joined in the celebration by showcasing us on the trading floor. We are truly grateful to the NYSE for this recognition. 👏Since our founding in May 2018 in Pleasan